Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1083 studies found for:    ALA
Show Display Options
Rank Status Study
1 Not yet recruiting The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors
Condition: Central Nervous System Tumor, Pediatric
Intervention: Drug: 5ALA
2 Unknown  A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Condition: Glioma
Intervention: Drug: 5-Aminolevuline Acid
3 Completed Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood
Conditions: Insomnia;   Nocturnal Awakening;   Irritability;   Coping Behavior;   Stress
Interventions: Dietary Supplement: 5-Aminolevulinic Acid (5-ALA);   Dietary Supplement: Placebo
4 Recruiting Fluorescence and Glioma Heterogeneity
Condition: Malignant Gliomas
Intervention: Procedure: ALA Test group
5 Withdrawn A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors
Condition: Brain Neoplasms
Intervention: Drug: 5-aminolevulinic acid
6 Unknown  Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain
Condition: Glioma
Intervention: Drug: 5-Aminolevuline Acid
7 Active, not recruiting Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
Condition: Glioblastoma
Interventions: Drug: 5-ALA;   Drug: Gliadel wafers
8 Recruiting 5-ALA in Recurrent Glioma
Condition: Glioma
Intervention: Drug: 5-ala
9 Recruiting Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
Condition: Actinic Keratosis
10 Recruiting Fluorescence-guided Surgery for Low- and High-grade Gliomas
Condition: Glioma
Interventions: Drug: 5-Aminolevulinic acid (ALA);   Drug: Placebo - ascorbic acid
11 Unknown  Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
Conditions: Primary Malignant Neoplasm of Nervous System;   Glioma;   Glioblastoma;   Metastasis
Interventions: Procedure: Interventional arm;   Procedure: Control arm
12 Withdrawn A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Condition: Lung Cancer in Normal and Malignant Tumors
Intervention: Drug: ALA-induced Fluorescence
13 Completed This Study Aims to Evaluate the Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy (PDT)
Condition: Actinic Keratosis
Interventions: Drug: BF-200 ALA;   Drug: MAL
14 Completed Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.
Condition: Actinic Keratosis
Interventions: Drug: Vehicle;   Drug: BF-200 ALA
15 Completed
Has Results
Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)
Condition: Multiple Actinic Keratoses
Interventions: Drug: BF-200 ALA cream;   Drug: MAL cream
16 Completed
Has Results
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
Condition: Actinic Keratosis
Interventions: Drug: Broad Area ALA 1-hour incubation;   Drug: Broad Area ALA 2 hour incubation;   Drug: broad area ALA 3-hour incubation;   Drug: Spot ALA 2 hour incubation;   Drug: Vehicle PDT;   Device: Blue Light Treatment
17 Active, not recruiting Microneedle Lesion Preparation Prior to ALA-PDT for AK on Face
Condition: Actinic Keratosis
Interventions: Drug: ALA;   Drug: Topical Solution Vehicle;   Device: IBL 10 mW;   Procedure: Microneedle lesion preparation;   Device: IBL 20 mW
18 Terminated A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
Conditions: Malignant Glioma;   Glioma;   Glioblastoma;   Glioblastoma Multiforme;   Astrocytoma
Intervention: Drug: Aminolevulinic Acid
19 Terminated Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Drug: 5-ALA plus Blu-Light;   Drug: 5-FU, Imiquimod or treatment with cryotherapy
20 Recruiting Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Conditions: Actinic Keratosis;   Natural Daylight Photodynamic Therapy
Interventions: Drug: Aminolevulinic Acid;   Drug: Methyl 5-aminolevulinate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years